Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells
- 1 November 2013
- journal article
- Published by Elsevier BV in Virology
- Vol. 446 (1-2), 268-275
- https://doi.org/10.1016/j.virol.2013.08.002
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5R21AI076145)
This publication has 67 references indexed in Scilit:
- Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptorBlood, 2010
- Establishment of HIV Latency in Primary CD4+Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb RestrictionJournal of Virology, 2010
- Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite ControlPLoS Pathogens, 2010
- Induction of HIV-1 latency and reactivation in primary memory CD4+ T cellsBlood, 2009
- Second-Generation Anti–Carcinoembryonic Antigen Designer T Cells Resist Activation-Induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines, and Exhibit Superior Antitumor ActivityIn vivo: A Preclinical EvaluationClinical Cancer Research, 2008
- Discontinuation of Antiretroviral Therapy in Patients with Chronic HIV Infection: Clinical, Virologic, and Immunologic ConsequencesAIDS Patient Care and STDs, 2005
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- HLA-DRα chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopesHuman Immunology, 1994
- Mouse CD4 binds MHC class II with extremely low affinityInternational Immunology, 1993
- A strategy for evaluating lymphokine activation and novel monoclonal antibodies in antibody-dependent cell-mediated cytotoxicity and effector cell retargeting assaysCancer Immunology, Immunotherapy, 1990